Your body is adjusting to its new weight
thch ng Qunh Anh mua ti rocy.vn c xp hng 5 5 sao Shop giao hng rt nhanh lun, t bui ti m hm sau c ri
Liraglutide (Saxenda, Victoza) Liraglutide is another GLP-1 agonist, marketed as Saxenda for weight management and Victoza for type 2 diabetes
Wegovy, Saxenda and Zepbound are approved for weight loss in the following individuals: Adults with an initial BMI of 30, defined as obesity Adults with an initial BMI of 27, defined as overweight, with at least one weight-related comorbid condition Weight-related comorbid conditions include high blood pressure, cardiovascular disease (such as coronary artery disease, heart attack or heart failure), high cholesterol, obstructive sleep apnea, type 2 diabetes, fatty liver, GERD/acid reflux, osteoarthritis, urinary incontinence, etc
Thm v o , ti cm thy sc khe ca mnh cng c ci thin, da d khng cn kh rp na